volibris
glaxosmithkline (ireland) limited - ambrisentan - hypertenzia, pľúca - antihypertenzív, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.
violetta
gedeon richter plc., maďarsko - gestodén a etinylestradiol - 17 - anticoncipientia
kostya 0,02 mg/0,075 mg obalené tablety
gedeon richter plc., maďarsko - gestodén a etinylestradiol - 17 - anticoncipientia
mirelle
bayer ag - gestodén a etinylestradiol - 17 - anticoncipientia
logest
bayer ag, nemecko - gestodén a etinylestradiol - 17 - anticoncipientia
femoden
bayer ag, nemecko - gestodén a etinylestradiol - 17 - anticoncipientia
lindynette 30
gedeon richter plc., maďarsko - gestodén a etinylestradiol - 17 - anticoncipientia
lindynette 20
gedeon richter plc., maďarsko - gestodén a etinylestradiol - 17 - anticoncipientia
sunya
heaton k.s., Česká republika - gestodén a etinylestradiol - 17 - anticoncipientia
katya
heaton k.s., Česká republika - gestodén a etinylestradiol - 17 - anticoncipientia